Conference Report

Update on HIV Drug Resistance

Source: CCO Independent Conference Coverage of the 2007 International HIV Drug Resistance Workshop*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Update on HIV Drug Resistance

Faculty:
Daniel R. Kuritzkes, MD Jonathan M. Schapiro, MD

CME CREDIT INFORMATION

Release Date: 08/30/07

Expiration Date: 08/29/08

Physicians: maximum of 1.25 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Summarize the results of recent studies regarding the clinical impact of resistance to antiretroviral agents
Discuss new data on the genotypic correlates of reduced susceptibility to antiretrovirals
Describe recent insights into resistance aspects of investigational antiretroviral agents

Topics covered include:

Introduction
Resistance and Failure With CCR5 Antagonists
Are Genotyping Tools Too Insensitive for Tropism Calls?
Risk of Cross-Resistance to Integrase Inhibitors
Resistance to Etravirine in DUET 1 and 2
NNRTI and Dual-Class Resistance in ACTG 5142
Protease Mutations in a PI Monotherapy Trial
Response to Darunavir After (Fos)Amprenavir Experience
Activity of Atazanavir Against Non–Subtype B HIV
Resistance Evolution With an All-NRTI Holding Regimen
Covert Pretreatment NNRTI Mutations Predict Failure
Novel Viral-Tagging Technique to Detect Occult Mutations

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.